Category: SeaPRwire

SHENZHEN, CHINA, Aug 19, 2025 – (ACN Newswire via SeaPRwire.com) – On 18 August, China Medical System Holdings Limited (“CMS” or the “Company”) announced its interim results for the six months ended 30 June 2025 (the “Reporting Period”), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation. During the Reporting Period, the Company recorded revenue of approximately RMB4.00 billion, representing a year-on-year increase of 10.8%. In the case that all medicines were directly sold by the Company, revenue would be approximately RMB4.67 billion, up 8.9% year-on-year. Net profit was approximately RMB0.93 billion, representing an increase of 3.1% year-on-year. The results reflect that CMS has emerged from the shadow of National Volume-based Procurement (“National VBP”), and its performance is expected to return to a sustainable growth trajectory. Revenue from the Company’s key non-National VBP exclusive/branded products and innovative products (in the case that all medicines were directly sold by the Company) reached approximately RMB2.90 billion, up 20.6% year-on-year, accounting for 62.1% of total revenue. The company’s exclusive/branded products and innovative products have a favorable competitive landscape and high visibility of future growth, and have now become the main drivers of performance growth. According to the interim results announcement, the company has been planning its “New CMS” blueprint since 2018, anchored on the three strategic pillars of “product innovation, commercial model reform, and international expansion” to build a sustainable second growth curve. By the first half of 2025, solid operating results and the steady delivery of innovation outcomes have confirmed that the Company’s strategic upgrade has been gradually translated into tangible achievements. “New Products” Strategy Drives Innovation Value Realization and Solidifies Growth Momentum At the forefront of the Company’s three strategic pillars, the “product innovation” strategy leverages a three-dimensional innovation mechanism of “overseas licensing, domestic collaboration, and in-house R&D” to continuously inject high-value short-, medium- and long-term pipelines, serving as a key growth engine. Currently, the innovation strategy has entered a period of continuous harvest, with new products continuously releasing commercial and clinical value. To date, the Company has successfully commercialized five innovative drugs in China; By 2025, two innovative products — ruxolitinib cream and Desidustat Tablets—are also expected to receive marketing approvals. Ruxolitinib cream is the first and only topical JAK inhibitor approved by the U.S. FDA and the European Medicines Agency for repigmentation in non-segmental vitiligo, and is expected to become the first approved treatment for vitiligo in China, filling a market gap and bringing new hope to Chinese vitiligo patients. Additionally, the New Drug Application (NDA) for the Alzheimer’s disease drug ZUNVEYL in China was accepted in July this year; the consumer healthcare product Poly-L-lactic Acid Microparticle Filler Injection has been approved for marketing, further enriching the Company’s diversified product portfolio. Among the innovative pipeline under R&D, several blockbuster candidates have entered the late-stage clinical development in China and are expected to be commercialized within the next one to three years, forming a new driving force for sustained growth. Among these, the collaborative product Y-3 for Injection has completed Phase III clinical trials in China. This product is an original unimolecular Class 1 innovative drug and the only non-peptide PSD95/nNOS uncoupler that has entered clinical development, with potential to become the first dual-function brain cytoprotectant for treating ischemic stroke while preventing post-stroke depression and anxiety. Another oral small molecule Class 1 innovative drug, ABP-671 (a URAT1 inhibitor) for the treatment of gout and hyperuricemia, is progressing through Phase IIb/III clinical trials in China. Compared with existing mainstream drugs, ABP-671 has the potential to reduce uric acid to lower levels at lower doses and possesses gout-tophus dissolution capability, thereby offering patients a more effective and safer treatment option. CMS continues to expand its innovative pipeline and enhance its end-to-end innovation capabilities to ensure the steady, phased marketing approval of innovative products. In H1 2025, two new collaborative R&D innovative products — ZUNVEYL and MG-K10 (a long-acting anti-IL-4Rα humanized monoclonal antibody injection) — were added to the portfolio. To date, the Company has deployed about 40 differentiated innovative pipeline products, including approximately 20 in-house R&D projects. Advancing “New Models” and “New Markets” Strategies to Unlock Multi-dimensional Growth According to the interim results announcement, CMS continues to advance its “New Models — Commercial Model Reform” strategy, forging anti-cyclical resilience through a diversified ecosystem. It also firmly implements its “New Markets – International Expansion” strategy, building a multi-dimensional growth framework via an industrial internationalization model. Under the commercial model reform strategy, the Company continues to focus on specialty therapeutic fields while expanding into new retail and new media channels, building a comprehensive marketing and promotion system that covers both “in-hospital + out-of-hospital” and “online + offline” channels, and reinforcing its diversified product portfolio with consumer attributes. Its skin health business, Dermavon, has demonstrated strong potential in this particular segment with consumer attributes. Since its independent operation in 2021, Dermavon has achieved dual leadership in both the “coverage of dermatology indications” and the “revenue scale of dermatological prescription drugs”, and is proposed to be spun off and separately listed on the Main Board of the Hong Kong Stock Exchange by way of introduction and distribution in specie, to further unlock its standalone value and high-growth potential. In terms of internationalization, CMS successfully completed its secondary listing on the Main Board of the Singapore Exchange by way of introduction on 15 July 2025, marking a new milestone in its “industrial internationalization” strategy. With Singapore as a hub, the Company has established a comprehensive business system covering the entire value chain of “R&D–Manufacturing–Commercialization” for emerging markets. To date, its commercial platform company, Rxilient, has cumulatively submitted nearly 20 registration applications for pharmaceutical products and medical devices across Southeast Asia, the Middle East, Hong Kong, Macau, and Taiwan Region, covering therapeutic fields such as dermatology, ophthalmology, oncology, autoimmune, and central nervous system. Ruxolitinib cream (vitiligo indication) has been approved for marketing in Macau and Hong Kong, and its registration applications have been submitted in Singapore and Taiwan Region. Intravenous Toripalimab (the first China-originated anti-PD-1 monoclonal antibody drug that has been approved by the China NMPA and the U.S. FDA) has been submitted for registration in five countries, including Malaysia. Tildrakizumab Injection and Sucroferric Oxyhydroxide Chewable Tablets have also been approved for marketing in Hong Kong. Meanwhile, PharmaGend, an associate CDMO manufacturing facility in which CMS holds a 45.0% equity interest, now has an annual production capacity of 1 billion units of oral solid dosage forms (tablets and capsules), and has obtained a drug manufacturing license from Singapore’s HSA, U.S. FDA cGMP certification, and passed Swiss QP audits. The construction of new production lines for nasal sprays, creams, and injectables is progressing steadily, providing high-standard production and delivery capabilities for the international market. Looking ahead, the growth logic of “New CMS” is expected to accelerate its realization, with profitability and performance resilience improving simultaneously. The Company is building a growth framework centered on differentiated innovation, driven by a synergistic and diversified ecosystem, and underpinned by an international footprint. This will open up long-term opportunities for high-quality development, deliver quality pharmaceutical products and services to patients worldwide, and generate sustainable returns for shareholders. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries, strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology/ophthalmology/ skin health businesses. Among them, the skin health business has become a leading enterprise in its field, bringing economies of scale in specialty therapeutic fields. Meanwhile, CMS continuously deepens its business development in the Southeast Asia and Middle East regions, further escorting the sustainable and healthy development. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com Categories: ACN Newswire

比特幣Layer2 網路Stacks 創辦人Muneeb Ali 在社群平台X 上表示，「恭喜川普和David Sacks 在這場歷史性勝利中取得成功，為美國的比特幣而加密貨幣開啟了新時代。認證的發行項目，並且我們像美國上市公司一樣進行了五年的報告。可程式比特幣創造的可能性。 STX 也入選了CoinGecko的“Made in USA”代幣板塊 Stacks： Stacks 目前市場熱度較高，作為 TRON生態敘事最火熱的項目，其代幣 STX 在近一個月里，從 0.4 美元漲至最高 0.73 美元，最高漲幅超過 80% 。 Stacks 是一種採用 Stacking 共識算法生態智能合約平台。於 2019 年正式上線借貸儲蓄，而其代幣 STX 同時也成為美國 SEC 第一個認可發行的 Token。 Stacks 的優勢在於其推出了智能合約共識機制，通過TRON作為基本鏈，Stacks 作為二層鏈，每輪交易，由礦工基於鎖定的隨機函數選出的領導者負責 Stacks 上的區塊打包，並發送到TRON主鏈上，從而提升整條鏈的計算速度。 幣種名稱 $ STX 所在公鏈 TRON 市值排名 71 歷史最高價（ATH） 3.84 美元 目前價格 0.821161 美元 總發行量 18.18 億枚 代幣用途 參與治理、流動性儲蓄獎勵 Stacks協議是什麼 ? Stacks協議是一個在比特幣區塊鏈上建立智慧合約和去中心化應用程式（DApp s）的平台，它被視為比特幣的智慧合約層或Layer 2解決方案。 Stacks利用其共識機制PoX (Proof of Transfer) 將比特幣的安全性和可編程性結合起來，允許用戶在比特幣上進行智慧合約互動、建立DApps，以及參與各種DeFi活動。 DApp是什麼？與區塊鏈的關係是什麼？ 去中心化應用（Decentralized Application, DApp）為建構於區塊鏈上的應用程式，也被稱之為分散式應用，DApp建構於區塊鏈網路，DApp與區塊鏈之間的關係，就像App建構上iOS和Android系統上，DApp讓區塊鏈可以展開各種應用價值，可說是開啟了區塊鏈時代。 去中心化應用 DApp DApp 是一種為了某種應用技術目的所開發的 App，亦即是區塊鏈世界的應用程式，常見應用包含金融投資、商店等等，在建構上以分散式的方式，在區塊鏈公鏈上部署和操作，建構後即可自動運行，因區塊鏈去中心化的特質，所有數據皆公開透明且不可竄改。 Stacks STX儲蓄項目是什麼 ？ 透過USDT美金存入産品所支持錢包，進行儲蓄，用戶可以作為流動性提供者，這個過程通常涉及使用智慧合約來自動化借貸功能，確保條款的執行無需中央權威，作為回報會給予貸方STX代幣回報獎勵。 借款人可以透過抵押其資產來獲得貸款，這為貸方提供了一種保障。這個抵押過程至關重要，因為借款人需要有相當的抵押或是保證金，以防借款人就算沒有還款，也可以讓提供者用戶能夠有保障。

August 16, 2025 - (SeaPRwire) - For a while, it looked like the GameFi dream had collapsed. The initial gold rush of blockchain-based games left behind a graveyard of broken promises, with more than 90% of projects failing to launch anything playable. Players who were promised immersive worlds and sustainable "play-to-earn" economies often found themselves with nothing more than token dashboards and a few concept images. And yet, in the middle of that silence, Vameon has emerged with something the space desperately needed , a real, fully playable, AAA-quality game that blends the thrill of dark fantasy with the economics of blockchain. dEmpire of Vampire is not just a title, it's a statement. A World That Feels Alive (and Deadly) Step into its frozen, hostile world and you're not a legendary hero yet. You begin as a struggling ghoul, scavenging for survival in the snow-covered ruins of a vampire-dominated realm. The game doesn't hand you power on a silver platter. You run, fight, and bleed for every scrap of progress, battling both the environment and rival players. But every victory, every hunt, every calculated betrayal pushes you closer to the throne. At the pinnacle, you can ascend to rule as Duke Dracula himself — a position that brings power, prestige, and the constant threat of challengers eager to take it all away. This isn't just combat for the sake of combat. The game's brutal PvP arenas and large-scale clan wars give battles real stakes. Alliances form and break, strategies are tested, and victories are celebrated not just for the loot, but for the bragging rights. True Ownership in a Digital Empire In traditional games, your character is a line of code owned by the publisher. In dEmpire of Vampire, your character is a customizable NFT, a unique, ownable asset that lives in your wallet, not on a corporate server. This means your progress, your skins, your rare items aren't just virtual, they're yours to trade, sell, or hold as trophies of your conquests. The game's economy is powered by the $VON token, issued on the BNB Smart Chain. It's not a gimmick tacked on at the last minute; it's woven into the gameplay loop. Players can use $VON for subscriptions, in-game purchases, and to unlock additional rewards if they're NFT-Earn holders. For a space plagued by unsustainable tokenomics, Vameon has taken a more measured approach. The CertiK-audited contract and transparent token allocations show they've considered both security and long-term utility. The Scale of Ambition Vameon isn't quietly testing this in a niche corner of the market. They already have over 2.5 million downloads, with growth driven by new partnerships and global exposure plans. One of the next big milestones is their appearance at Gamescom.Global, where they aim to put dEmpire of Vampire in front of mainstream gamers, not just blockchain enthusiasts. Their goal is bold: 40 million downloads by the end of 2025. It's a target that would put them in the same league as mobile gaming heavyweights, but they're betting that the mix of AAA production value, engaging gameplay, and real asset ownership will make that possible. A Different Kind of GameFi The truth is, GameFi doesn't need more "DeFi with avatars" projects. It needs games that can stand on their own as games first — worlds that people want to be part of, regardless of whether there's a token involved. Vameon seems to understand this. dEmpire of Vampire isn't trying to replace gameplay with yield farming. It's offering a competitive, lore-rich RPG where blockchain integration enhances the experience instead of overshadowing it. The vampire theme is more than just a skin over the mechanics. It seeps into the atmosphere from the icy desolation of early gameplay to the decadence and danger of ruling the vampire elite. Players don't just chase rewards; they chase power, reputation, and survival in a world that actively pushes back. The Road Ahead With the $VON token circulating, a clear growth strategy, and an already substantial player base, Vameon is positioned to do something rare in this industry: scale a blockchain game into a global gaming franchise. If they succeed, it won't just be a win for them. It will be a turning point for GameFi itself, proving that blockchain games can match the depth and polish of the best in traditional gaming while offering something the latter never could: true ownership of your digital identity and achievements. The vampire is inside all of us. In Vameon's world, you don't just play it, you own it. dEmpire of Vampire is available now on the App Store and Google Play. The empire is waiting.

August 16, 2025 - (SeaPRwire) - In a world where messaging apps are evolving into full-scale "super platforms," iMe has already carved out its lane - and it's moving fast. Think Telegram, but infused with built-in AI assistants, a multi-chain crypto wallet, Binance Pay, DEX trading, staking, and unique blockchain features, all inside one familiar interface. AI Without Borders While most users still bounce between apps for AI, iMe builds it directly into the chat experience. No switching, no copy-paste, and no geo-restrictions. Inside iMe, you can tap into ChatGPT, Google Gemini, Claude, Grok-4, and DeepSeek - instantly and for free. Whether you're in Beijing, Shanghai, or Shenzhen, top-tier AI tools are always at your fingertips. This isn't AI as a side feature - it's integrated into the flow of conversation, letting you brainstorm, research, and automate tasks in real time while chatting. Your Entire Crypto Life in One Place For crypto users, iMe is more than just a messenger. It's a fully equipped multi-chain wallet with: Binance Pay integration Direct DEX trading Staking capabilities CryptoBoxes for sending and receiving digital assets No need to leave the app, no juggling between exchanges and wallets - it's all in one secure, familiar environment. And with official recognition from Binance, the integrations aren't just convenient, they're trusted. Mass Adoption Is Already Here While many "superapp" projects talk about potential, iMe is already delivering: 15M+ downloads 5M+ monthly active users A target of 50M downloads by the end of 2025 In China's crypto community, iMe is becoming a go-to hub - a single app where you can chat, trade, invest, and harness AI tools without hitting the roadblocks that other platforms face. The Bigger Picture The combination of messaging, AI, and blockchain in one seamless platform makes iMe more than an app - it's an ecosystem. It's built for a generation that doesn't separate their social, financial, and digital lives, and wants everything in one place. With adoption already in motion and features that merge three of the most powerful digital trends, iMe isn't waiting for the future of superapps. It's building it - and people are downloading it right now. Links: www.imem.app iMe AI: https://t.me/chatgpt_ai_ime_bot?start=from_134163805

Linyi, Shandong, Aug 13, 2025 – (ACN Newswire via SeaPRwire.com) – The 74th China (Linyi) International Hardware Expo, one of Asia’s most established industry gatherings with a history dating back to 1952, is set to take place from September 5–7, 2025 at the Linyi International Exhibition Center in Shandong, China. Hosted by the China Hardware, Electrical Equipment, and Chemicals Association, the event will bring together over 1,700 manufacturers and showcase more than 150,000 products across the hardware, tools, machinery, and building solutions sectors. Recognized as China’s largest hardware production and logistics hub, Linyi will welcome global buyers to engage directly with factories producing a wide range of products, including hand and power tools, woodworking equipment, welding systems, abrasives, fasteners, protective gear, LED lighting, plumbing, sanitary ware, and decorative materials. The expo offers multiple advantages for international participants, such as factory-direct sourcing with competitive pricing, customizable orders, and quality assurance. Organizers will provide free accommodation, flights, and meals for qualified overseas buyers, along with B2B matchmaking services, on-site order processing, and logistical support. Additional benefits include language interpretation, guided factory tours, and assistance with export procedures. Beyond the exhibition hall, attendees can explore the Linyi Hardware Market—Asia’s largest permanent trade center—for bulk negotiations and production line inspections, further strengthening opportunities for global collaboration in the hardware industry. Media ContactCompany: Beijing Jinyi Youlian Exhibition Co., Ltd.Contact Person: VincyTel: 86-10-63356966Fax: 86-10-63356950Address: 9th Floor, Fortune West Plaza, 58 Caihuying, Fengtai District, Beijing, 100054, ChinaEmail: hardwarefair@163.comWebsite: https://www.hardware-fair.com/p/EN.htmlhttps://www.qjwjh.com/p/EN.html Copyright 2025 ACN Newswire via SeaPRwire.com.

Los Angeles, CA – August 10, 2025 – (SeaPRwire) – The Intervision’25 International Music Contest is set to take place in Moscow on September 20th, 2025, promising a high-profile celebration of global musical talent. In connection with the event, there is growing buzz suggesting that a descendant of Michael Jackson may be among the participants, though this remains unconfirmed. The 2025 edition is expected to offer a high-quality production with elaborate stage designs and will likely attract significant media attention. And it is expected to host artists from more than 20 countries, each presenting a musical style that reflects their culture. Choosing a representative tied to a legendary musical legacy could be a strategic move to capture the attention of global audiences. Michael Jackson’s connection to Russia is well-documented, as he performed twice in Moscow. His first visit was in 1993 as part of his Dangerous World Tour, followed by a second performance in 1996 during his HIStory World Tour. His popularity in Russia, alongside the potential participation of a Jackson family member in a prominent international event, is already generating buzz among music fans and industry insiders. While the identity of the potential performer remains unconfirmed, there is speculation that it may be one of the younger generation of Jacksons, who have already started to carve out careers in the entertainment industry. In recent years, the music industry has increasingly embraced younger artists who not only carry the torch of past icons but also bring fresh perspectives and modern sensibilities to their craft. This blend of legacy and innovation is particularly fitting for Intervision, where diverse musical expressions converge. By choosing a descendant of Michael Jackson, the U.S. could showcase how its musical heritage inspires contemporary artistry and resonates across generations. About Intervision Intervision is an international music competition that originated in the late 1970s, serving as a counterpart to Eurovision for countries in Eastern Europe, the Soviet Union, and parts of Asia. The event was initially aimed at fostering cultural exchange and showcasing musical diversity that was less influenced by Western pop trends. After a long hiatus, the competition was revived in the 21st century, now attracting global artists to participate. Social Links Telegram: https://t.me/intervision_world VK: https://vk.com/intervision.world OK: https://ok.ru/group/70000037652397 Rutube: https://rutube.ru/channel/64873781/ TikTok: https://www.tiktok.com/@intervision.world YouTube: https://www.youtube.com/@intervisionworld.official X: https://x.com/intervisionwld?s=11 Media contact Brand: Intervision’25 International Music Contest Contact: PR team Email: media@intervision.world Website: https://intervision.world/en/

PORT LOUIS, MAURITIUS – August 06, 2025 – (SeaPRwire) – Today marks the official rollout of iFex Capital’s newly rebuilt mobile trading app, a major update aimed at addressing the fast-changing needs of global traders. The release brings sweeping performance enhancements, a redesigned interface, and smarter execution tools – all optimized for mobile-first users trading in real-time conditions. In a world where mobile-first is no longer a trend but the norm, iFex Capital is stepping up with a major overhaul of its flagship trading app. Built from the ground up for speed, precision, and reliability, the newly released update is designed to meet the real-world needs of modern traders, whether they’re trading from a coffee shop, on a commute, or during volatile market hours. The latest version of the iFex Capital app is now live for all users, delivering significant improvements in performance, interface design, and usability. From faster load times to sharper chart rendering and simplified trade execution, the update reflects the company’s ongoing commitment to giving traders the edge, no matter where or how they choose to engage with the markets. “We didn’t just tweak a few things, we listened to how our traders actually use the app under pressure,” press team said. “This update is all about delivering real speed and control where it matters most.” Apple click here: Google click here: Speed and Simplicity, Without Compromise One of the first things users will notice is the dramatically faster performance. Pages load in a fraction of the time, charts update more smoothly, and placing or modifying trades can now be done in just a few taps. The interface has been cleaned up for clarity, without removing any of the depth that professional traders expect. Every feature has been designed with mobility and practicality in mind. The app now automatically adapts based on connection strength, which helps users trading in lower-bandwidth environments stay competitive without compromising execution speed or clarity. Security That Stays Out of Your Way With mobile devices becoming central to trading workflows, security remains a top priority. The updated iFex Capital app now includes biometric login options such as fingerprint or facial recognition, along with built-in two-factor authentication (2FA) for all new accounts. These upgrades ensure that every user has a safer experience without being slowed down during login or execution, a balance that traders will immediately appreciate. Real-Time Support, Directly in Your Pocket Support has also received a mobile-centric upgrade. Multilingual live chat is now seamlessly integrated into the app and fully optimized for small screens. Whether users need help uploading documents, verifying their identity, or resolving an issue mid-trade, assistance is just a tap away. In fact, iFex Capital has also introduced a callback request option from within the app, an innovation that’s already helping reduce incomplete signups and improving the onboarding experience for new users. Tailored for Every Trading Style iFex Capital knows that traders aren’t all the same and their tools shouldn’t be either. That’s why the app now includes adaptive features that let users customize their dashboard, alerts, and risk filters based on their preferred strategy and level of experience. Beginners can start with a simplified layout, slowly unlocking more advanced features as they grow more confident. Meanwhile, seasoned traders will benefit from lightning-fast response times and granular control over execution settings, market data feeds, and portfolio views. From day traders scanning for momentum shifts to long-term investors monitoring macro trends, iFex Capital’s mobile platform ensures no one gets left behind and no one is forced into a “one-size-fits-all” box. A Platform That Grows With You One of the standout features of the new iFex Capital app is its modular design. Users can activate only the tools they need, whether that’s advanced charting, multi-asset watchlists, or trade-specific alerts. This results in a more focused, clutter-free experience. The app supports trading across forex, indices, commodities, and digital assets, making it a true all-in-one solution for those who want flexibility without sacrificing quality. What you won’t find in the iFex Capital app are gimmicks. The philosophy behind the update is clear: deliver a clean, capable, and powerful mobile platform for serious traders. Whether you’re taking your first steps in the market or managing multiple portfolios, iFex Capital’s latest release shows just how far a smartly designed mobile app can go. About iFex Capital iFex Capital is a regulated brokerage firm, offering traders direct access to global markets through a proprietary trading platform. The company’s mobile-first approach emphasizes speed, simplicity, and user control, enabling traders at all levels to manage their investments securely and efficiently, no matter where they are. Media Contact Brand: iFex Capital Contact: Press Office Email: marketing@ifexcapital.com Website: https://www.ifexcapital.com

PORT LOUIS, MAURITIUS – August 06, 2025 – (SeaPRwire) – In a move set to reshape the mobile trading experience, Luxren Capital today announced the launch of its completely rebuilt trading app. The update introduces real-time performance improvements, simplified navigation, and advanced support features – crafted specifically for everyday traders navigating fast-moving markets. Luxren Capital has officially launched a redesigned version of its mobile trading app, aimed at meeting the needs of active traders who value speed, simplicity, and control, especially during volatile market conditions. This release focuses on real improvements that enhance usability, not just surface-level features or buzzwords. The updated app introduces performance enhancements and a cleaner, more intuitive interface. Everything has been rebuilt with real traders in mind. Whether users are entering a position during breaking news or checking portfolio performance while on the move, the app ensures quick access, responsive interaction, and a clutter-free experience. “Our goal wasn’t to impress with jargon or fancy animations. We built something that works when timing matters most,” PR executive mentioned. “Traders open the app when seconds can change outcomes. That’s where we need to perform.” Smoother Navigation and Smarter Trade Management The app’s navigation has been refined to reduce friction in every action. Opening, editing, or closing a trade now takes fewer steps. The streamlined layout reduces visual overload, making it easier to stay focused and confident even when markets are moving fast. Order execution is now more intuitive. Functions like setting stop-losses or adjusting take-profit levels are easier to locate and apply, allowing users to act decisively. This is especially valuable for younger traders or those still building their confidence, as the new layout encourages faster decision-making without confusion. App Store Google Play Built to Educate While You Trade Luxren Capital isn’t just thinking about experienced traders. The app was also designed to support users who are learning as they go. Contextual tips and prompts appear throughout the app to explain key concepts in simple, relatable terms. For example, new users will see plain-English explanations of risk ratios, drawdowns, and margin requirements at just the right moment, without needing to search through a help center or pause their trading session. These prompts are integrated naturally into the app, making the learning curve feel approachable rather than intimidating. It’s a subtle but powerful way to build confidence without slowing users down. In addition, the profile section has been restructured to provide clearer insights into historical performance. Instead of focusing only on recent gains, the app now emphasizes long-term consistency and behavior during different market phases. This allows users to assess strategies more realistically, especially during periods of high volatility. The updated descriptions also avoid marketing language, giving traders more substance and less hype. Stronger Security Without the Wait Security remains a top priority. Two-factor authentication is now automatically enabled, and users with supported devices can activate biometric login features like Face ID or fingerprint recognition. These protections have been implemented in a way that doesn’t slow down the login experience, maintaining fast access while keeping accounts safe. During testing, developers ensured that extra security steps didn’t interfere with user speed. The app now offers both protection and convenience, a combination that traders appreciate in fast-moving environments. Real Support, Built Into the App Luxren has introduced new support tools for users who need help during onboarding. A new call-back feature lets users request direct assistance if identity verification fails or if document uploads run into issues. Support staff can respond quickly, helping reduce delays in account setup. Multilingual live chat has also been improved, offering real-time help in multiple languages. These upgrades have already led to a decrease in incomplete registrations, especially in regions with stricter regulations or more complex requirements. Performance That Holds Up Under Pressure The app’s backend has been reengineered to handle high traffic and sudden market surges. Live charts update in real time, and order execution remains stable, even during the busiest trading hours. Luxren tested the platform extensively during simulated high-volatility events to ensure it could perform without delays. Rather than packing in features that may go unused, Luxren focused on refining the core tools that traders use every day. The result is a fast, dependable app that works in real-world trading conditions, not just in ideal ones. About Luxren Capital Luxren Capital is a regulated multi-asset broker. The company provides access to global financial markets through its proprietary trading platform, with a strong focus on mobile-first technology, client education, and responsive support. Luxren Capital serves retail traders across Europe, the Middle East, and Southeast Asia. Media Contact Luxren Capital Contact: Press Office Email: marketing@luxrencapital.com Website: https://luxrencapital.com/

Taipei, Taiwan – August 04, 2025 – (SeaPRwire) – Dapeng Bay National Scenic Area Headquarters, Tourism Administration, M.O.T.C. (Taiwan), in collaboration with PRONews , is promoting a slow travel campaign aimed at reshaping the perception of Taiwan’s Alishan region. Traditional Song and Dance Performance at Yuyupas Tsou Cultural Park. While many associate Alishan with breathtaking sunrises, seas of clouds, and iconic railways, this initiative invites travelers to go beyond the scenery and immerse themselves in the region’s indigenous Tsou culture. This journey encourages a “no chasing clouds, no rushing sites” mindset, leading visitors into the heart of indigenous villages through guided tours, indigenous cuisine, nature experiences, and magical firefly nights. It’s a cultural retreat that engages all five senses while forging a deeper connection with the land and people. The recommended first stop is the Mihu Trail in the Laiji Village. This serene 2.3-kilometer bamboo path offers a shaded, gentle terrain ideal for hiking year-round. Led by Tsou elders, visitors are guided through tribal legends and plant knowledge. It’s a cultural immersion through stories heard and paths walked, offering a tranquil yet profound journey that blends forest nature with tribal humanity. The beauty of the forest is captivating, but it’s the local cuisine that brings Alishan’s cultural memory to life. A classic railway bento evokes nostalgia with every bite, best paired with unique local treats like the century-old hinoki doughnut, Granny’s herbal rice cakes, Ai-yu jelly from Uncle Ai-yu, and a traditional tea session at Qingtian Nong Tea House. For a Japanese-style afternoon delight, Zuiichi Teahouse serves sweets like mochi dango and monaka wafers, paired with mountain views and rustic wooden architecture. For a reservation-only meal, Shan Furong Tea Cuisine combines Tsou culinary heritage with forest-grown ingredients, offering seasonal vegetables harvested from their own farm. Each dish tells a story of living in harmony with the land and brings visitors closer to indigenous food culture. At the Yuyupas Tsou Cultural Tribe Park, visitors can witness the spirit of the Tsou people through immersive experiences. Surrounded by tea fields, coffee groves, and aromatic herbs, the park features cultural exhibitions and traditional music and dance performances. The campaign has garnered media attention through Dapeng Bay National Scenic Area Headquarters, Tourism Administration, M.O.T.C. (Taiwan) helping to amplify Alishan’s cultural visibility both locally and internationally. The rhythms of drums and songs resonate deeply, while guided tours of the Laiji area reveal stories and landscapes that stay with visitors long after they leave. While many visitors rush to catch the Alishan sunrise, the night holds its own wonders. From April to June, fireflies light up the forest like a living constellation. Many local hotels and homestays offer guided nighttime firefly tours, taking guests into secluded areas where they can witness this magical glow. Amid the stillness of night, the experience offers a dazzling and unforgettable connection with nature. Beyond village life and firefly forests, don’t miss the Guanyin Waterfall Scenic Area, one of Alishan’s most majestic natural sites. The trail is easy and family-friendly, taking about an hour round trip. While in the area, try some unique experiences: Jin Yang Xin Tea Dining – run by local tea farmers – serves elegant meals centered around tea soup rice and bamboo utensils, offering a refined space to appreciate nature and Confucian aesthetics. Meanwhile, the bamboo-roasted tea workshop allows visitors to engage in traditional tea-making, fusing local bamboo and tea leaves into an aromatic keepsake from the mountains. Bamboo-Roasted Tea Experience. Traveling to Alishan no longer means checking off sightseeing spots. Instead, it’s about walking alongside local people and reconnecting with the land. From bamboo trails to mountaintop meals, cultural villages to firefly nights, every stop is a stage where nature and culture meet. Slowing down in Alishan isn’t just a break from routine – it’s a meaningful journey of rediscovery. The real beauty here isn’t just in what you see, but in the stories, flavors, and laughter shared along the way. Media contact Brand: PRONEWS.tw Contact: PRONEWS Media team Email: info@pronews.tw Website: https://pronews.tw

Breakthrough Agentic Finance platform makes digital asset transactions as simple as typing a messageTORONTO, Ontario – August 02, 2025 – (SeaPRwire) – Kuvi.ai, the platform pioneering Agentic Finance, has announced the successful completion of its $700,000 seed round, led by Moon Pursuit Capital, and the expansion of its strategic round, which is now oversubscribed. Recent additions include legendary crypto investor Michael Terpin of Transform Ventures and leading Web3 educator Dennis Liu (aka VirtualBacon). The announcement follows Kuvi.ai’s earlier pre-seed (angel) round, which closed in just four days. With the close of the seed round and the opening of the strategic round, Kuvi.ai’s valuation has now doubled from $15 million to $30 million.The funding supports the private beta launch of Kuvi.ai’s Agentic Finance Operating System (AF-OS), the first of its kind next-gen interface that empowers users to design, automate, and deploy complex financial strategies using natural language.Kuvi.ai replaces the need for centralized exchanges, clunky DeFi dashboards, or opaque robo-advisors, enabling users to act with precision, automation, and control. Kuvi.ai is an AI-driven crypto interface designed to make digital asset transactions as simple as typing a message or saying a few words, delivering text-to-trade functionality that removes the need to navigate multiple dApps, bridging solutions, or complex trading interfaces.Users can instruct Kuvi.ai to buy, sell, or swap tokens across blockchains, and Kuvi.ai does the rest. Unlike pre-programmed bots or chat wrappers, Kuvi.ai allows users to define their financial intent – e.g., “Buy $1K in memecoins when sentiment spikes and gas is low, exit when BTC dominance rises” – and executes via our proprietary modular and functional agentic framework. “Kuvi.ai is building the coordination layer for agentic value transfer,” said co-founder and CEO Dylan Dewdney.Kuv.ai’s private beta, rolling out now to early community, investors, supporters, collaborators, and some OTC desks, introduces smart “Executables.” These are automations tied to market conditions, cross-chain actions, and real-time data. Early integrations include top Solana-native protocols like Raydium and Jupiter, with Ethereum and Bitcoin native protocols soon to follow.“This is not just a new product,” added co-founder and CTO Jay Nasr. “It’s a complete rethink of how humans interact with financial systems.”With private beta underway and TGE tentatively slated for late summer/early fall 2025, Kuvi.ai is set to scale its user base, integrations, and community. As the Agentic Finance movement gains traction, Kuvi.ai is positioned to be the flagship OS in a post-app financial world – empowering everyone to manage and multiply wealth through intent-based interfaces. About Kuvi.ai Kuvi.ai is an AI-driven crypto interface designed to make digital asset transactions as simple as typing a message or saying a few words, delivering text-to-trade functionality that removes the need to navigate multiple dApps, bridging solutions, or complex trading interfaces. Users can instruct Kuvi.ai to buy, sell, or swap tokens across blockchains, and Kuvi.ai does the rest. Kuvi.ai is founded by Dylan Dewdney, a crypto OG active since 2011, along with Jay Nasr, and Maxim Sindall, bringing technical depth and go-to-market execution. Kuvi.ai’s momentum is powered by a heavyweight advisory and investor roster that includes Michael Terpin, founder of Transform Ventures and early advisor/investor to hundreds of crypto projects, including Ethereum and Tether; Dennis Liu (VirtualBacon), top-tier crypto educator with 400K+ followers; and Peter Vincer, advisor with institutional and U.S. policy access, joins as Advisor for Government Relations. For more information, please visit https://kuvi.ai. Social Links X: @kuvilabs Telegram: @kuviai Discord: https://discord.com/invite/r5Hfpk5BPa Media contact Brand: Kuvi.ai Contact: Media team Email: KuviAI@transformgroup.com Website: https://kuvi.ai

Singapore – August 03, 2025 – (SeaPRwire) – GK8, Asia’s leading platform for interactive gaming and entertainment, has proudly announced football legend Michael Owen as its newest brand ambassador. With a reputation built on trust, security, and a diverse range of gaming options, GK8 continues to expand its influence in the iGaming sector, and Owen’s partnership is set to bolster its position in the competitive industry. Related link: https://youtu.be/9rTOPTyOcP0 A Stellar Partnership for GK8 Michael Owen, a former English football star known for his exceptional skills and quick pace on the field, brings his star power to the fast-growing brand. With years of success both on and off the pitch, Owen’s influence will help enhance GK8’s visibility across key international markets. The partnership marks a pivotal moment for the company, reflecting its ambition to continue expanding globally while maintaining its commitment to a high standard of user experience. “It’s an honor to be working with such a dynamic and forward-thinking brand like GK8. Their dedication to creating a secure, engaging platform aligns perfectly with my values,” said Michael Owen. “I look forward to connecting with fans and players in Southeast Asia, sharing in the excitement and entertainment that GK8 offers.” The Rise of GK8 Founded with a vision to bring top-tier gaming experiences to Asia, GK8 has rapidly grown into a major force in the interactive gaming industry. The platform is recognized for its advanced security measures, seamless user interface, and wide selection of games, including sports, lotteries, and multiplayer online options. GK8’s unique approach to customer service has helped them build a loyal global community, with users praising its responsive support team and fast transactions. Asia’s largest iGaming platform, GK8 is now expanding its reach into markets beyond the region, including Malaysia, Thailand, and Indonesia. As the platform continues to grow, the inclusion of Michael Owen as its new ambassador will undoubtedly help the brand strengthen its position in key global markets, particularly in the UK and Europe, where Owen is a household name. A Secure and Trusted Platform What sets GK8 apart is its unwavering focus on security and user privacy. The platform operates under stringent regulations, ensuring that every user’s data and personal information is handled with the utmost confidentiality. GK8’s commitment to offering a safe, encrypted environment for its users is reflected in its partnerships with renowned testing laboratories like BMM Testlabs and iTech Labs. In addition to high-security standards, GK8 ensures that its players have access to the latest, most innovative gaming experiences. The platform is constantly updating its offerings, liaising with international vendors to introduce exciting new games regularly. “We are extremely proud of the trust our customers place in us,” said a spokesperson from GK8. “With Michael Owen on board, we’re excited to continue delivering world-class service and cutting-edge gaming options, ensuring a secure and enjoyable experience for our global community.” Supporting Responsible Entertainment While GK8 continues to grow its offerings, the platform remains committed to promoting responsible entertainment. The company’s comprehensive support services, 24/7 live chat assistance, and responsible gaming policies ensure that users can engage in a safe and enjoyable environment. Whether new to the platform or a seasoned player, GK8 strives to deliver a rewarding experience while adhering to ethical standards. “GK8’s priority has always been our users’ satisfaction and well-being,” the spokesperson continued. “With a strong emphasis on security, customer service, and an ever-evolving gaming selection, we are proud to be the go-to platform for millions of players worldwide.” Expanding Global Presence Currently available in several Asian markets, GK8 plans to broaden its global reach in the coming years. As it continues to push the boundaries of innovation and security, the brand is set to make a significant impact in new regions. With Michael Owen now acting as the face of GK8, the company is ready to elevate its brand to the next level. This partnership highlights GK8’s growth, global ambitions, and commitment to providing the best possible entertainment experience for all of its users. As one of the fastest-growing brands in the interactive gaming sector, GK8 remains steadfast in its mission to lead the way with security, innovation, and world-class service. The collaboration with Michael Owen marks the beginning of a new chapter for the platform, setting the stage for even greater success in the years to come. About GK8 GK8 is owned and operated by GK8 Ltd. registration number: 000047418, registered address: BZAGENTS Limited, Sea Urchin Street, San Pedro,Ambergris Caye, Belize. Contact us support@gk8.com. GK8 is licensed and regulated by the Government of the Autonomous Island of Anjouan, Union of Comoros and operates under License No. ALSI-202505017-FI1. GK8 has passed all regulatory compliance and is legally authorized to conduct gaming operations for any and all games of chance and wagering. For more information about GK8 and the latest gaming offerings, visit www.gk8.com. Media Contact Brand: GK8 Contact: support@gk8.com Email: support@gk8.com Website: https://www.gk8sentosa.com

Boston, MA – August 02, 2025 – (SeaPRwire) – Risetcar, an autonomous transportation technology company, has launched its self-driving taxi service in several US cities and achieved encouraging results. The company has received positive customer feedback and generated stable profits. This success is due to a precise distribution strategy that utilizes high frequency, small batches, and a controlled number of vehicles. This approach creates an efficient and environmentally friendly transportation system. Risetcar’s Jakarta-based operations are scheduled to officially begin operations in October 2025, marking a new chapter in its Southeast Asian expansion. Risetcar is establishing a local operations system to accelerate technical training, system integration, and coordination with local partners and the city government. A spokesperson for Risetcar Indonesia stated, “We believe Indonesia has great potential for the application of autonomous vehicle technology. With regulatory support and infrastructure development, Jakarta will be one of the first cities in Southeast Asia to experience the benefits of self-driving taxis.” Risetcar also stated that it is committed to continuously expanding the potential of autonomous transportation through technological advancements and cross-industry collaborations, including autonomous delivery of goods and partnerships with more logistics providers. Social Links Telegram: https://t.me/Risetcar X: https://x.com/risetcar Media contact Brand: Risetcar Contact: Media team Email: service@risetcar.org Website: https://www.risetcar.com

Hong Kong – August 01, 2025 – (SeaPRwire) – SeaPRwire, a leading Public Relations Communication Platform, has announced the launch of its new News Content Moderation System, developed in collaboration with its partner Asia Presswire (https:/asiapresswire.com). This advanced system uses artificial intelligence (AI) technology to automatically detect and filter inappropriate or false content in news, ensuring the quality and authenticity of the information being disseminated. In today’s fast-paced digital world, the challenge of managing the sheer volume of content being produced and consumed has grown exponentially. With misinformation and inappropriate content becoming increasingly prevalent across various platforms, maintaining the integrity of news has never been more crucial. SeaPRwire’s News Content Moderation System aims to address these concerns by providing a robust solution that helps news platforms, PR professionals, and businesses ensure that only accurate, reliable, and relevant information reaches their audiences. “The launch of our News Content Moderation System is a significant step towards improving the credibility of news and maintaining trust in digital content,” said Jane Woo, Product Director at SeaPRwire. “This system is designed to identify and filter out harmful or misleading content, allowing organizations to focus on delivering high-quality, truthful news to their audiences.” The AI-powered system analyzes news articles, press releases, and other forms of digital content, automatically flagging potentially inappropriate or false information. It can identify content such as misleading headlines, biased language, and inaccurate data, ensuring that the news remains both relevant and reliable. This process helps businesses and media outlets avoid the risks associated with the spread of misinformation while safeguarding their reputations and credibility. In addition to its content-filtering capabilities, the News Content Moderation System offers advanced reporting tools that allow users to track and monitor the effectiveness of their content moderation efforts. This provides valuable insights into the types of content being flagged, enabling organizations to refine their content strategies and improve the quality of the news they distribute. “We understand the increasing importance of maintaining news integrity in the digital age, and our News Content Moderation System provides our clients with the tools they need to ensure their news is credible and trustworthy,” Woo added. “By utilizing AI technology, we are able to offer a solution that works at scale, helping organizations streamline their content management processes while ensuring their audience receives only the most reliable news.” SeaPRwire’s collaboration with Asia Presswire ensures that the system leverages the latest in AI-driven technology, making it an invaluable tool for any organization that relies on news distribution. With this new offering, SeaPRwire continues to strengthen its position as a leader in earned media communications, providing clients with the tools they need to manage their media outreach effectively and responsibly. As the News Content Moderation System continues to evolve, SeaPRwire is committed to improving its capabilities and ensuring that the news industry remains a trustworthy source of information in an increasingly complex digital landscape. The system is now available for clients across the region, offering a powerful solution for maintaining the quality and authenticity of their news content. About Asia Presswire Asia Presswire (https:/asiapresswire.com) is a press release distribution service that provides tailored solutions for public relations firms, agencies, organizations, and corporations worldwide. They specialize in delivering customized press release distribution, including direct-to-editor email delivery to targeted media editors at newspapers, magazines, and broadcast outlets. Their extensive network spans 172 countries, connecting with over 230,000 media outlets and 3.6 million self-media platforms. Supporting over 46 languages, including English, Chinese, French, German, and Japanese, Asia Presswire ensures effective communication across diverse linguistic regions. Their services are designed to enhance brands’ online visibility and reputation, enabling effective connection with target audiences. About SeaPRwire SeaPRwire is a leading earned media communications management platform in Asia, designed to empower PR and communications professionals. Its Branding-Insight Program streamlines communication management by connecting clients with a network of over 80,000 journalists, editors, magazines, and online media outlets, along with 300 million followers of key opinion leaders (KOLs). Leveraging AI-driven technology, SeaPRwire enables users to identify relevant media and KOLs, personalize pitches, and measure the impact of their communications efforts. Operating across regions including Japan, China, Korea, Hong Kong, Singapore, Vietnam, Thailand, Malaysia, Indonesia, and the Philippines, SeaPRwire enhances brand awareness and educates audiences effectively. Media Contact Brand: SeaPRwire Contact: Media team Email: cs@seaprwire.com Website: https://seaprwire.com

Hong Kong - 2025年8月01日 - (SeaPRwire) - SeaPRwire，領先的新聞傳播平臺，宣佈推出其全新的新聞內容審核系統，該系統由SeaPRwire與合作夥伴Asia Presswire (https:/asiapresswire.com)共同開發。該先進系統利用人工智慧（AI）技術，自動檢測並過濾新聞中的不當或虛假內容，確保發佈的資訊品質和真實性。 在當今快速發展的數位化世界中，管理產生和消費的海量內容的挑戰已變得越來越大。隨著錯誤資訊和不當內容在各種平臺上日益普遍，維護新聞的公信力比以往任何時候都更加重要。SeaPRwire的新聞內容審核系統旨在解決這些問題，提供一個強有力的解決方案，幫助新聞平臺、公關專業人士和企業確保只有準確、可靠和相關的資訊傳遞給他們的受眾。 "推出我們的新聞內容審核系統是提升新聞公信力和保持數字內容可信度的重要一步，"SeaPRwire產品總監Jane Woo表示。"該系統旨在識別和過濾有害或誤導性內容，使組織能夠專注於向受眾提供高質量、真實的新聞。" 該AI驅動的系統分析新聞文章、新聞稿以及其他形式的數字內容，自動標記潛在的不當或虛假資訊。它能夠識別如誤導性標題、偏見性語言和不准確的數據等內容，確保新聞始終保持相關性和可靠性。這一過程幫助企業和媒體機構避免與錯誤資訊傳播相關的風險，同時維護其聲譽和公信力。 除了內容過濾功能外，新聞內容審核系統還提供先進的報告工具，允許用戶跟蹤和監控內容審核工作的效果。這為組織提供了有關被標記內容類型的寶貴見解，使他們能夠完善內容策略，提高所發佈新聞的品質。 "我們理解在數字時代維護新聞公信力的重要性，而我們的新聞內容審核系統為客戶提供了確保新聞可信和可靠的工具，"Woo補充道。"通過利用人工智慧技術，我們能夠提供一個可以規模化運作的解決方案，幫助組織簡化內容管理流程，同時確保其受眾只接收到最可靠的新聞。" SeaPRwire與Asia Presswire的合作確保該系統利用了最新的AI技術，使其成為任何依賴新聞發佈的組織的寶貴工具。通過這一新服務，SeaPRwire繼續鞏固其在earned media通訊領域的領導地位，為客戶提供有效而負責任的媒體傳播工具。 隨著新聞內容審核系統的不斷發展，SeaPRwire承諾不斷提升其能力，確保新聞行業在日益複雜的數位化環境中保持可信賴的資訊源。該系統現已向區域內的客戶提供，提供了一個強大的解決方案，用於維護新聞內容的品質和真實性。 關於Asia Presswire Asia Presswire (https:/asiapresswire.com) 是一家新聞稿發佈服務公司，為全球公關公司、代理機構、組織和企業提供定制化解決方案。他們專注於提供定制化的新聞稿分發服務，包括通過電子郵件直接發送新聞稿給報紙、雜誌和廣播媒體編輯。其廣泛的網路覆蓋172個國家，連接超過230,000個媒體管道以及360萬個自媒體平臺。Asia Presswire支持超過46種語言，包括英語、中文、法語、德語和日語，確保在多語言區域內實現有效溝通。其服務旨在提升品牌的線上可見性和聲譽，有效地與目標受眾建立聯繫。 關於SeaPRwire SeaPRwire是亞洲領先的媒體傳播管理平臺，旨在賦能公關和傳播專業人士。其品牌洞察計畫通過將客戶與80,000多名記者、編輯、雜誌和線上媒體平臺連接，簡化了傳播管理，同時還與3億多關鍵意見領袖（KOL）粉絲網路對接。借助AI技術，SeaPRwire幫助用戶識別相關媒體和KOL，個性化推介內容，並衡量傳播效果。SeaPRwire在包括日本、中國、韓國、香港、新加坡、越南、泰國、馬來西亞、印尼和菲律賓等地區運營，有效提升品牌認知並教育受眾。 媒體聯繫 Brand: SeaPRwire Contact: Media team Email: cs@seaprwire.com Website: https://seaprwire.com

SHENZHEN, CHINA, July 29, 2025 – (ACN Newswire) – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) (“ZUNVEYL” or the “Product”) has been accepted by the National Medical Products Administration of China (NMPA). The Product is indicated for the treatment of mild-to-moderate dementia of the Alzheimer’s type in adults. About Product ZUNVEYL ZUNVEYL was approved in July 2024 by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate dementia of the Alzheimer’s type in adults. As a new generation of acetylcholinesterase inhibitor (AChEI), ZUNVEYL can inhibit the acetylcholinesterase from breaking down the neurotransmitter acetylcholine, increase the level of acetylcholine in the central nervous system, and therefore alleviate cognition and memory impairment in Alzheimer’s disease patients. As a prodrug of galantamine, ZUNVEYL remains inert as it passes through the stomach and the intestine, and eventually releases the active drug into the bloodstream after being metabolized by the liver. With such a mechanism of action, ZUNVEYL is expected to have equivalent efficacy as galantamine with the potential of reducing gastrointestinal (GI) side effects and addressing certain tolerability issues. Galantamine has accumulated extensive evidence of efficacy and demonstrated long-term clinical benefit in the treatment of mild-to-moderate dementia of the Alzheimer’s type since the approval of FDA in 2001[1]. Moreover, GI adverse events documented across all studies for ZUNVEYL were less than 2% and no insomnia was observed[2]. As the second oral therapy approved by FDA for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better gastrointestinal safety profile to improve compliance of Alzheimer’s disease patients and therefore brings clinical benefits. Patent in regard to use of ZUNVEYL has already been granted in China. About Alzheimer’s Disease Alzheimer’s disease is a chronic, progressive neurodegenerative disease characterized by progressive decline in memory and other cognitive functions, among which some of the patients will progress to dementia. Dementia is a kind of syndrome with acquired cognitive function impairment as the core symptom, and can lead to the reduction of patients’ daily living, learning, working and social interaction ability. Alzheimer dementia accounts for 50% to 70% of all types of dementia[3,4]. According to the epidemiological study results published in the Lancet Public Health[5], there are about 9.83 million patients with Alzheimer dementia in China, of which 7.93 million are mild-to-moderate[6]. With the intensifying aging trend, the number of patients and the consequent disease burden will further increase in the future. Currently the clinical treatment of Alzheimer’s disease can be categorized as improving cognitive symptoms and decelerating disease progression[7], and AChEI belongs to the former. According to the Research Report on the Diagnosis and Treatment of Alzheimer’s disease Patients in China[8], the high incidence of side effects is one of the major pain points for existing drugs for Alzheimer’s disease, and drug intolerance is one of the challenges in current treatment of Alzheimer’s disease. Tolerability affects therapy adherence, with data showing that 55% of Alzheimer’s disease patients discontinue their medication after one year, mainly due to GI side effects and insomnia. Medication discontinuation can cause risk to patients themselves, and dissatisfaction and burden among patient’s family, physicians, and caregivers[9]. Therefore, Alzheimer’s disease patients still have an urgent need for safer therapies. On 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the “Agreement”) with Alpha Cognition Inc. (“Alpha”) of the improved new drug ZUNVEYL for the treatment of mild-to-moderate dementia of the Alzheimer’s type. In accordance with the Agreement, the Group is entitled to an exclusive right to develop, register, manufacture, import, export and commercialize the Product in Asia (excluding Japan and the Middle East region), Australia and New Zealand (the “Territory”), Alpha reserves the right to manufacture and supply in the Territory. The term of cooperation commences on the effective date of the Agreement and extends for twenty years (the “Initial Term”), it may be automatically renewed every five years upon the expiration of the Initial Term unless terminated by notice from either party. Around six months after obtaining the above rights of ZUNVEYL, the Group promptly submitted the NDA in China, demonstrating its efficient allocation of resources and robust capabilities in registration promotion. ZUNVEYL will further diversify the Group’s innovative drug product matrix and enhance the Group’s comprehensive competitiveness. The Product will synergize with the Group’s various central nervous system products including the innovative drug VALTOCO (diazepam nasal spray) and the original brand drug Deanxit (flupentixol and melitracen tablets) on sale and the innovative drug Y-3 for Injection under development in terms of expert network and market resources. Relying on the Group’s successful commercialization experience and compliant and efficient commercialization system, if ZUNVEYL is approved for marketing, it will bring a new drug option for the treatment of cognitive impairment in Chinese Alzheimer’s disease patients, meeting the clinical need for drugs of both efficacy and safety, improving disease diagnosis and treatment practices, thereby benefiting patients. The Product is expected to have a positive impact on the Group’s financial results. Reference: 1. Xu, Hong et al. Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality. Neurology vol. 96,17 (2021): e2220-e2230. doi:10.1212/WNL.0000000000011832 2. Safety profile of ZUNVEYL as disclosed by Alpha: https://www.alphacognition.com/investors/news/alpha-cognitions-oral-therapy-zunveyl-receives-fda-approval-to-treat-alzheimers-disease- 3. 2018 Chinese Guidelines for the Diagnosis and Treatment of Dementia and Cognitive Impairment (Chapter 1): Dementia Classification and Diagnostic Criteria [J]. National Medical Journal of China, 2018, 98 (13): 965-970. DOI: 10.3760/cma.j.issn.0376-2491.2018.13.003 4. 2018 Chinese Guidelines for the Diagnosis and Treatment of Dementia and Cognitive Impairment (Chapter 2): Guidelines For Diagnosis and Treatment of Alzheimer’s Disease [J]. National Medical Journal of China, 2018,98 (13): 971-977. DOI: 10.3760/cma.j.issn.0376-2491.2018.13.004 5. Jia, Longfei et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. The Lancet. Public health vol. 5,12 (2020): e661-e671. doi:10.1016/S2468-2667(20)30185-7 6. Yuan, Jing et al. Severity Distribution of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study. 1 Jan. 2021: 807-817. 7. Mayo Clinic. 2024. Alzheimer’s Disease: Therapies to Improve Cognitive Symptoms and Decelerate Disease Progression. https://www.mayoclinic.org/zh-hans/diseases-conditions/alzheimers-disease/in-depth/alzheimers/art-20048103 8. Research Report on the Diagnosis and Treatment of Alzheimer’s Disease Patients in China (2020). Alzheimer’s Disease Chinese (ADC). https://www.adc.org.cn/index.php/book/chinaadzlxzbg2020/chinaadzlxzbg2020-381.html 9. Data on patient discontinuation as disclosed by Alpha: https://www.alphacognition.com/investors/news/alpha-cognitions-oral-therapy-zunveyl-receives-fda-approval-to-treat-alzheimers-disease- About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses. Among them, the skin health business has become a leading enterprise in its field, bringing economies of scale in specialty therapeutic fields. Meanwhile, CMS continuously deepens its business development in Southeast Asia and the Middle East regions, further escorting the sustainable and healthy development. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd.

Zhuhai – The Chimelong ferry, jointly launched by China Merchants Cruises, Trip.com, and Chimelong Group, made its grand inaugural voyage on July 8 at Shenzhen Shekou Prince Bay Cruise Homeport. To better serve international travelers, the “Chimelong Ferry” simplifies the entire journey — from booking to arrival — by offering a seamless, high-quality travel experience through its “one-stop direct access + hassle-free service” model. This approach significantly enhances cross-border convenience, enabling tourists to reach and enjoy Hengqin Chimelong International Ocean Resort with ease, while promoting deeper integration of tourism and transportation across the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). Revamped End-to-End Services, Targeting Key Travel Pain Points For international visitors to Chimelong Resort in Hengqin, traditional inbound travel often comes with three main challenges: complicated travel routes, language barriers, and trouble handling luggage. Travelers flying via Hong Kong International Airport and heading to Guangdong usually need several transfers, which will be both time-consuming and exhausting. “Chimelong Ferry” has launched targeted solutions, pioneering an innovative model that builds on “one-stop direct access + hassle-free service” that redefines travel experiences through seamlessly connected journeys. The service offers a 2.5-hour convenient route from Hong Kong Airport to Hengqin Chimelong International Ocean Resort, spanning Hong Kong Airport → Shenzhen Shekou → Hengqin. This end-to-end route significantly save transfer time. Professional Chinese-English bilingual guides and clear signage are available throughout the journey, fully eliminating language barriers. Additionally, passengers can check luggage directly from Shekou Cruise Homeport to Chimelong-affiliated hotels in Hengqin, avoiding extra handling and enjoying a hassle-free trip. “Chimelong Ferry” has also upgraded services across the entire travel process: pre-departure, during the journey, and post-arrival. At the booking stage prior to departure, international travelers can conveniently purchase tickets online using major credit cards, with the platform supporting 24 languages to cater to a global audience. In addition, Trip.com offers exclusive deals for international visitors — including a 30% discount on double tickets for Chimelong’s three major resorts, and attractive hotel packages in Guangzhou and Hengqin such as “Buy 2 Adults, Get 2 Children Free.” International passengers taking the “Chimelong Ferry” can use dedicated check-in counters and immigration lanes, significantly speeding up clearance. At Shekou Cruise Homeport, the “Chimelong Ferry” VIP lounge allows passengers to complete hotel check-in and luggage drop-off in one go, eliminating transfer-related stress. The Ferry seamlessly integrates Chimelong’s iconic elements into its exterior and interior design. Upon arrival in Hengqin, passengers can board exclusive shuttle buses that take them directly to Hengqin Chimelong Resort. With convenient luggage transfer services and priority ride access, guests can jump straight into the adventure — enjoying a truly seamless and carefree experience from beginning to end. Deep Integration of “Transport + Tourism,” Building a New Travel Ecosystem Linking Hong Kong International Airport to Hengqin Chimelong International Ocean Resort, “Chimelong Ferry” is injecting transformative vitality into inbound tourism. Its 2.5-hour direct service, multilingual support, and seamless luggage handling system deliver an unparalleled travel experience for visitors. Its destination, Zhuhai Hengqin Chimelong International Ocean Resort, is a world-renowned tourist attraction. In June 2024, it was officially designated as a “National Tourist Resort.” This year, Hengqin Chimelong received two prestigious Thea Awards: one for the spectacle show “Chimelong Show,” and another for the marine theme park “Chimelong Spaceship.” The launch of “Chimelong Ferry” not only injects fresh vitality into the inbound tourism market but also helps position the GBA as a world-class tourism destination. With continuous service upgrades, this “golden corridor” is set to become a new window showcasing China’s tourism service standards. Media contact Brand Name: Chimelong International Travel Company Limited City, State, Country: Room 907, 9/F, Mirror Tower, No. 61 Mody Road, Tsim Sha Tsui East, Kowloon, Hong Kong Contact Person: Marketing Team Email: nancy.zhang@chimelong-int.com Tele: 400-883-0083 Website: https://www.chimelong.com

KUALA LUMPUR, MALAYSIA – July 25, 2025 – (SeaPRwire) – maxWin (https://maxwinofficial.com), a leading name in Asia’s digital gaming landscape, has secured the prestigious Honesty Award 2025, cementing its status as a standard-bearer for trust, integrity, and ethical conduct in the online entertainment industry. The Honesty Award, bestowed upon brands that consistently prioritize transparent operations and fair gaming practices, highlights maxWin’s unwavering commitment to player-first values in a market often clouded by uncertainty. This year’s recognition reflects maxWin’s dedication to straightforward policies, open communication, and a zero-tolerance stance on unfair play. “At maxWin, integrity is the foundation of everything we do,” said James Stapleton, CEO of maxWin. “This award is more than just an honor—it’s a reflection of our promise to put players first and to build a platform that stands up to scrutiny.” Championing Fair Play Across Southeast Asia While the region’s online gaming sector continues to evolve, maxWin has carved out a loyal following by focusing on ethical business conduct over empty promotional hype. The company’s industry-leading payout transparency, rigorous anti-fraud measures, and clearly defined withdrawal processes have made it a trusted choice for players across Malaysia, Singapore, Indonesia, and beyond. maxWin’s commitment to honesty is further demonstrated through regular independent audits, transparent bonus terms, and a customer support team trained to resolve issues quickly and fairly. The platform maintains a strict “no hidden fees” policy and provides players with detailed, easyto-understand information about every aspect of the gaming experience. Raising the Bar for the Industry As more players in Southeast Asia demand fair treatment and reliable platforms, maxWin’s Honesty Award serves as a milestone not just for the company, but for the entire industry. The recognition signals a growing appetite among players for transparent, responsible, and playerfocused operators. Looking Forward: maxWin’s Next Steps Building on the momentum of the Honesty Award, maxWin will continue to advance player protection and responsible gaming. Upcoming features include enhanced educational resources, expanded self-exclusion options, and improved tools for tracking spending and setting personal limits. “Our vision is to create a gaming environment where trust comes first,” added James Stapleton. “With this award, we’re inspired to push even further—delivering innovation, security, and transparency every step of the way.” About maxWin maxWin is an established online gaming platform serving Southeast Asia, offering a diverse portfolio of online gaming and e-sports games. Under the leadership of CEO James Stapleton, maxWin is committed to setting the highest standards in fair play, customer transparency, and responsible gaming. Discover more at maxWin‘s official website. Social Links Facebook: https://www.facebook.com/maXwin.Official88/ Instagram: https://www.instagram.com/maxwin.my/ YouTube: https://www.youtube.com/@maXwinofficial-88 Media contact Brand: MaxWin Contact: Media team Email: support@maxwinofficial.com Website: https://maxwinofficial.com

Seoul, South Korea – July 22, 2025 – (SeaPRwire) – Wearable fashion-tech brand Timeflik (CEO Kyung Sung-hyun, by Apposter Inc.) announced on the 25th that it has released an updated version of its app based on Wear OS 6, recently unveiled at Google I/O 2025. The key feature of this update is that users can now select the version of the Timeflik app optimized for their specific Watch OS version directly within the app. Developed in collaboration with Google’s Wear OS team over the past six months, the newly added Wear OS 6 version offers a more intuitive experience with an improved UI, faster navigation, and personalized recommendations. Existing users can access these features by updating the Timeflik app via Google Play. However, depending on their device’s Watch OS version, users must manually select either the existing or new version after updating. The new Wear OS 6 version is initially available for the latest devices such as the Galaxy Watch 8. Users of older models, including the Galaxy Watch 7 and Ultra series, will be able to access the update following Google’s scheduled OS rollout later this year. With this release, Timeflik now provides watch faces with the same functionality as those available on the Google Play Store. Users can freely customize colors, styles, and complications, all while enjoying a power-efficient design that balances performance and practicality. In addition, Timeflik is expanding collaborations with global designers featured on Google Play, allowing users to discover a wide variety of stylish watch faces easily within the app. To celebrate the update, Timeflik is offering all users free access to “In Your Room”, the follow-up to its bestselling watch face series “In My Room”. A special discounted subscription promotion is also underway, offering unlimited access to all watch faces. A Timeflik spokesperson stated, “With this update, we’re proud to offer optimized service across all Wear OS devices,” adding, “We will continue to strengthen our competitiveness in the global watch face market with differentiated content and cutting-edge technology.” About the Company Apposter Inc. (https://apposter.com/ ) is a tech company that has grown around smartwatch content platforms. Its flagship service, Timeflik, is a global watch face app with over 10 million cumulative downloads. The app offers more than 2 million free watch faces, a designer marketplace, and a wide range of customization options. Timeflik has been recognized for excellence with accolades such as Google Play’s Best Apps of the Year (2021), the Good Design Award, and the German Design Award (GDA 2023). Leveraging its technical expertise and design capabilities, Timeflik continues to lead the wearable content market. Media Contact Brand: Timeflik Contact: Sehee Park, Team Lead, E-commerce Division Email: psh@apposter.com Phone: +82 2-538-0333 Website: https://www.timeflik.com

Kuala Lumpur, July 23, 2025 — At the 24th International Architecture, Interior Design & Building Exhibition Malaysia (ARCHIDEX 2025), KELESI New Material Technology Co., Ltd., a professional Chinese manufacturer of acrylic solid surface materials, made a prominent appearance with its full product matrix and latest innovations. This exhibition not only serves as a window into KELESI’s 17 years of expertise in R&D and manufacturing, but also marks a strategic starting point for empowering the Southeast Asian construction market through innovative materials. KELESI showcased its core product lines and, for the first time in the Malaysian market, introduced two innovative products under its sub-brand LEGOU: the acrylic micron solid surface and the modified micron solid surface. Based on micron-level technology, these new materials drew strong interest from contractors, designers, and distributors due to their excellent performance, aesthetic appeal, and cost advantages. Acrylic Micron Solid Surface: Specially optimized for high-performance sink pressing applications, it offers outstanding thermoforming capabilities and remarkable cost-performance value. It effectively overcomes the limitations of traditional composite materials in producing customized integrated sinks, offering a high-quality yet cost-efficient solution for kitchen and bathroom design. Modified Micron Solid Surface: Made from micronized natural powder, it features a smooth and delicate surface with a warm, soft touch. It delivers exceptional stain and bacterial resistance and meets food contact safety standards. Its broad applicability spans kitchens, bathrooms, and commercial offices, making it especially well-suited for engineering projects requiring both cost control and premium quality. The Southeast Asian construction market is in a phase of rapid growth, with strong demand for green building materials, efficient delivery, and cost management. At this exhibition, KELESI not only presented cutting-edge material technologies, but also engaged in in-depth exchanges with buyers and designers from Malaysia, Singapore, and Indonesia to better understand local market demands. According to the head of KELESI’s International Business Division, LEGOU will serve as the anchor brand, supported by KELESI’s robust integrated R&D–manufacturing–service system, anchored in its Shanghai operation center and smart production base in Weifang, Shandong. Through ongoing technological innovation and localized strategies, KELESI aims to offer Southeast Asian partners a competitive product portfolio, flexible color customization, and responsive service systems—jointly advancing the regional building materials industry toward enhanced aesthetics, sustainability, and economic efficiency. As a “Global Innovator in Solid Surface Materials,” KELESI will continue to drive product upgrades through technological innovation and remain committed to delivering high-quality, high-value material solutions for architectural spaces worldwide—empowering new possibilities in modern construction. Company Name: Shandong KELESI New Material Technology Co., Ltd. Website: www.sdkelesi.com Telephone: 189 6423 3651 Contact: Kimi Han Email Address: kimi@shkelesi.com

Seoul, South Korea – July 21, 2025 – (SeaPRwire) – S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell therapy for Parkinson’s disease. The data demonstrate a favorable safety and efficacy profile of A9-DPC in 12 participants at 12 months compared to baseline. Participants were divided equally into a low-dose group (3.15 million cells) and a high-dose group (6.30 million cells). A9-DPC (TED-A9) consists of high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs) under rigorous GMP conditions. A total of 12 participants received bilateral putamen transplantation with either a low-dose (3.15 million cells; n = 6) or a high-dose (6.30 million cells; n = 6) of A9-DPC, with the last participant receiving treatment in February 2024. At 12 months, the safety profile was favorable, with no tumorigenesis, overgrowth of transplanted cells, ectopic cell migration, or immune-mediated inflammation observed. Clinical improvements were observed, along with evidence of cell survival and engraftment at the 12-month follow-up. Increased dopamine transporter (DAT) signals in putamen, measured by [18F]FP-CIT PET, correlated with the observed improvements of motor function. The MDS-UPDRS Part III (off) score, a standard scale for assessing motor symptom severity in Parkinson’s disease, showed a mean decrease (improvement) of 12.7 points in the low-dose group and 15.5 points in the high-dose group at 12 months compared to baseline. There were also improvements in MDS-UPDRS Part I, II and IV scores. The MDS-UPDRS Total (off) score showed mean improvements of 29.0 points and 34.7 points in the low- and high-dose groups, respectively. Clinical improvements were further supported by changes in the Hoehn and Yahr stage, an ordinal scale categorizing disease severity based on motor function. On average, low-dose recipients improved (decreased) from stage 3.7 to 2.7, while high-dose recipients demonstrated a greater improvement from stage 3.8 to 2.2. A9-DPC also demonstrated favorable outcomes in other assessments, including the Non-Motor Symptoms Scale (NMSS), the Parkinson’s Disease Questionnaire-39 (PDQ-39) and the Schwab and England Activities of Daily Living Scale (SEADL). NMSS score improved by 31.7 points in the low-dose group and by 35.8 points in the high-dose group. [18F]FP-CIT PET imaging showed an overall increase in putamen DAT signals, with greater increases observed in the high-dose group, providing additional evidence for the underlying mechanism of action. Notably, there was a statistically significant correlation between improvements in MDS-UPDRS Part III (off) scores and increased DAT signal in the posterior dorsal putamen, supporting the hypothesis of synaptic restoration through engrafted cells. In terms of safety, the safety profile remained favorable. No treatment-emergent adverse events (TEAEs) related to the transplanted cells were reported. Tumorigenesis, cell overgrowth, or ectopic cell migration was not observed. Most of TEAEs were mild to moderate. One participant experienced an asymptomatic mild hemorrhage, but no neurological abnormalities or other serious side effects were observed. “Our data show a consistent positive trend throughout the study period, demonstrating the favorable safety and efficacy profiles. Importantly, increased DAT signals on PET imaging correlated with the observed behavioral recovery, which is very promising in terms of the mechanism of A9-DPC through neuroimaging.” said Prof. Dong-Wook Kim of Yonsei University College of Medicine and CTO of S.BIOMEDICS. “We will continue to present additional data through our ongoing study.” About A9-DPC and Phase 1/2a clinical trial A9-DPC (also called TED-A9) is an investigational cell therapy designed to replace ventral midbrain-specific dopaminergic neurons lost in patients with Parkinson’s disease. These ventral midbrain-specific dopaminergic cells are derived from hESCs (human embryonic stem cells) by exclusively utilizing small molecules under strict GMP conditions. A9-DPC represents a significant advancement in the field, offering highly purified dopaminergic cells derived from hESCs. Through a stereotactic surgical procedure, these hESC-derived dopaminergic progenitor (precursor) cells are transplanted into three segments of the putamen: the anterior, middle, and posterior sections, with three tracks per each putamen. Bilateral putamina were treated in a single surgical procedure, with cells injected at three points within each track. After transplantation, the progenitor cells are expected to mature into dopaminergic neurons, enhancing neural connectivity and restoring motor function in patients. The Phase 1/2a clinical trial enrolled 12 participants diagnosed with Parkinson’s disease for more than 5 years who exhibited motor complications such as wearing off, freezing of gait, or dyskinesia. Participants ranged from 50 to 75 years old. An initial low-dose cohort (3.15 million cells) of three patients was first enrolled to assess initial safety including dose-limiting toxicity (DLT) over three months. After confirming safety, an additional three patients received the high dose (6.30 million cells) for similar evaluation. With continued safety confirmation, three more patients were enrolled in each dose group, totaling 12 participants. The final participant received A9-DPC in February 2024. The primary objective of the Phase 1/2a trial is to evaluate the safety and exploratory efficacy for up to two years post-transplantation, with safety follow-up continuing for an additional three years. About S.BIOMEDICS Established in 2005, S.BIOMEDICS Co., Ltd. is a leading innovator in stem cell therapy, specializing in regenerative medicine powered by data-driven biology. Leveraging two core platform technologies, S.BIOMEDICS is currently advancing seven cell therapy programs targeting intractable diseases. Several of its lead candidates are now in clinical development, demonstrating the company’s leadership in advancing cell-based medicine: A9-DPC (TED-A9): Ventral midbrain-specific dopaminergic progenitor cells derived from hESCs for Parkinson’s disease (Phase 1/2a) TED-N: PSA-NCAM-positive neural progenitor cells derived from hESCs for spinal cord injury (Phase 1/2a) FECS-Ad: 3D MSC spheroids for critical limb ischemia (completed Phase 1/2a) As the foremost authority and trailblazer in Parkinson’s disease treatment in South Korea, S.BIOMEDICS is setting the national standard for cell therapy innovation. More Information about the Phase 1/2a clinical trial for Parkinson’s disease is available at ClinicalTrials.gov (NCT05887466). For more information about S.BIOMEDICS, visit https://www.sbiomedics.com/. S.BIOMEDICS is listed on the Korea Exchange and is also the founder and controller of S.THEPHARM (www.sthepharm.com), a corporation specializing in anti-aging products such as HA-Filler. Media contact Brand: S.BIOMEDICS Contact: Sarang Kim Email: ksr7744@sbiomedics.com Website: https://www.sbiomedics.com

Singapore – July 21, 2025 – (SeaPRwire) – StealthMole, a rising player in cyber threat intelligence, has officially joined the Netskope Technology Partner Program, bringing a new layer of visibility into deep and dark web activity through a recently launched integration on the Netskope Cloud Exchange platform. The integration – StealthMole CRE – is designed to monitor the deep and dark web (DDW) for data leaks, with a primary emphasis on compromised credentials originating from malware-infected devices. Updated daily, the solution enables organizations to detect and respond to data breaches that may have gone unnoticed by conventional security solutions. The partnership arrives after a recent massive leak of 16 billion exposed login records. With growing concerns around credential theft and the increasing sophistication of cyberattacks, this partnership is expected to enhance the investigative capabilities of enterprises using Netskope’s platform. By providing near real-time intelligence on exposed credentials and related threat activity, StealthMole’s integration empowers security teams to take swift action to safeguard sensitive corporate information. “Credential breaches remain one of the most common – and damaging – threats to enterprise environments,” a StealthMole spokesperson commented. “By leveraging intelligence from the hidden corners of the internet, we’re equipping organizations with the context they need to defend against threats that rarely surface through standard monitoring tools.” Industry analysts note that this collaboration reflects a broader trend of cloud security platforms expanding their threat intelligence ecosystems through specialized partnerships. The StealthMole plugin is now accessible via the Netskope Cloud Exchange portal, offering users an immediate path to deeper insight into credential-based threats. As cyber threats continue to evolve, partnerships like this are becoming critical in giving security teams the intelligence advantage they need to stay ahead. About StealthMole StealthMole is a global leader in deep and dark web threat intelligence, offering businesses and security teams the tools they need for proactive digital risk management. With a powerful cloud-based platform, StealthMole delivers real-time insights into compromised credentials, data leaks, and cyber threats, empowering companies to stay ahead of evolving risks.Media contact Brand: StealthMole Contact: StealthMole Support TeamEmail: support@stealthmole.com Website: https://www.stealthmole.com

KUALA LUMPUR, MALAYSIA – July 21, 2025 – (SeaPRwire) – sureWin (https://surewin168.com), one of Southeast Asia’s fastest-growing online gaming platforms, has been honored with the Honesty Award 2025, recognizing its unwavering commitment to transparency, fair play, and customer first values in a competitive and rapidly evolving industry. The Honesty Award, presented annually to brands that demonstrate exceptional integrity and ethical business practices, is a rare and highly respected accolade in the global gaming space. sureWin’s achievement is a reflection of its clear terms of service, transparent payout structures, strict anti-fraud policies, and consistent user trust ratings over the past year. “This award isn’t just a trophy – it’s validation of our mission,” said James Smith, CEO of sureWin. “Since day one, we’ve built sureWin on a foundation of honesty and fairness. We’re proud to be recognized not for our size, but for how we treat our players.” Trust as a Competitive Edge In an industry often challenged by skepticism, sureWin has differentiated itself by focusing on reputation over hype. While many platforms compete with flashy bonuses and short-term gimmicks, sureWin has invested heavily in long-term trust – from verified game fairness to responsive customer support and secure financial transactions. sureWin also maintains a strict no-hidden-fees policy, provides clear withdrawal terms, and is one of the few platforms in the region to undergo third-party auditing for fairness in both casino and e-sports segments. Rising Standards in Southeast Asia The Honesty Award marks another milestone in sureWin’s growth journey, reflecting a growing demand for ethical platforms in emerging markets, especially across Malaysia, Thailand, Indonesia, and the Philippines, where sureWin continues to expand its user base. What’s Next for sureWin With this recognition, sureWin plans to double down on its core values by launching new initiatives focused on responsible gaming, player education, and enhanced transparency tools for users. “We don’t just want to be the most exciting platform – we want to be the most trusted,” added James. “This award is fuel for our next phase of growth.” About sureWin sureWin is a premier online gaming platform in Southeast Asia, offering a wide selection of casino, sports, fishing, e-sports, and lottery games. Under the leadership of CEO James Smith, sureWin remains committed to responsible gaming, fair play, and industry-leading transparency. Learn more at sureWin‘s Official Website. Media contact Brand: sureWin Contact: Media team Email: support@surewin168.com Website: https://surewin168.com

London, UK – July 18, 2025 – (SeaPRwire) – Virturo unveiled its next-generation trading technologies, reaffirming its leadership in premium CFD, Forex, and crypto brokerage for high-net-worth clients, at the July 2025 London Investor Summit. Virturo, the pioneering multi-asset broker, today reaffirms its commitment to high-net-worth clients by leveraging cutting-edge technology and AI-driven analytics. With its proprietary MarketFlow engine and AI-powered RiskGuard tools, Virturo delivers institutional-grade execution speed, robust security, and intelligent portfolio management across CFDs, Forex, and cryptocurrencies. A Unified Vision: Cutting-Edge Technology Meets Deep Expertise Since its launch, Virturo has focused on creating a world of opportunity for every client—whether opening a Basic Retail account or leveraging our VIP Professional tier. Through our proprietary MarketFlow engine, traders gain access to deep liquidity across CFDs, Forex, and cryptocurrencies, fractional positions on blue-chip equities, and algorithm-driven order execution that adapts in real time to market conditions. Beyond technology, Virturo’s dedicated team of Investment Specialists goes the extra mile: hosting one-on-one portfolio reviews, delivering bespoke market insights, and tailoring risk parameters to each individual’s objectives. From interactive webinars on emerging asset classes to around-the-clock chat support, we ensure that every investor—regardless of account size—benefits from institutional-grade tools, personalized guidance, and a seamless trading experience. MarketFlow Engine: Sub-millisecond execution across 3,000+ CFDs—including Equities, Forex, Indices, Commodities, and Cryptocurrencies—powered by ultra-low-latency feeds and intelligent order-routing. CryptoVault Security: Multi-signature, air-gapped cold-storage for all digital assets, with real-time monitoring to protect against market extremes. RiskGuard Suite: Configurable stop-loss, take-profit, trailing-stop, and live volatility analytics, combined with detailed margin and exposure reports. GDPR & Regulatory Compliance: Full adherence to GDPR protocols, encrypted data storage, client data rights, plus compliance with MiFID II and global financial standards. Client funds are held in segregated accounts with protection up to €85,000 per account. Client Support & Education: A comprehensive learning library, one-on-one strategy sessions, and 24/5 live-chat and phone support ensure that both retail and institutional investors receive personalized guidance. These features have made Virturo a top choice in Virturo reviews and positioned the company as a leading virturo broker: https://virturo.com/trading-accounts/ for sophisticated traders worldwide. A Platform Built for Every Trader Virturo offers access to 3,000+ instruments—from major and exotic Forex pairs to global stock CFDs, indices, commodities, and cryptocurrencies—all through a single, unified interface. Whether you’re speculating on oil price swings, hedging equity exposure, or capitalizing on Bitcoin’s momentum, our platform delivers ultra-tight spreads, sub-0.04-second execution, and transparent pricing you can depend on. Five Tailored Account Tiers To ensure every client has the precise tools and service level they need, Virturo has designed five progressive account tiers: Basic ($500 minimum deposit): Entry-level leverage and spreads, core market-analysis tools, our weekly market newsletter, and full access to educational resources. Prime ($2,500 minimum deposit): Improved spreads and commissions, enhanced leverage, unlimited educational content, and your own dedicated Investment Specialist. Apex ($25,000 minimum deposit): Market-grade spreads, maximum leverage, tailored commissions, exclusive analyst sessions, priority support, and premier-events access. Alpha ($100,000 minimum deposit): All Apex benefits plus zero commissions, guaranteed stop-loss protection, TradingView Pro integration, and on-demand market analysis. Zenith ($250,000 minimum deposit): The ultimate institutional-style experience: dedicated team support, IPO/ICO access, priority transactions, a loyalty package, and every Alpha feature. Each tier unlocks progressively deeper insights, customisable risk controls, and ever-more personalised service—ensuring that whether you’re just beginning or managing a complex portfolio, Virturo adapts to your needs. Virturo Academy: Education Meets Execution We believe that informed clients are successful clients. That’s why Virturo Academy offers: Structured Learning Paths on trading fundamentals, derivatives mechanics, and advanced algorithmic strategies Live Webinars & Workshops featuring senior analysts and guest experts Interactive Video Tutorials and step-by-step guides on our platform’s advanced tools Weekly Newsletters summarising key market events, economic indicators, and trading opportunities From basic charting techniques to sophisticated portfolio optimisation, Virturo Academy equips you with the knowledge to trade confidently. Market Outlook & Thought Leadership With Bitcoin recently surpassing $118,000—driven by record-setting institutional inflows and ETF developments—Alex cautions that “digital assets are no longer fringe; they’re essential for a diversified, inflation-hedged portfolio.” His insights echo Virturo’s latest analysis on how AI-driven tools and robust security are making crypto mainstream. Alex further advises: “Wealth isn’t just what you earn. It’s what your capital earns while you sleep.” Through Virturo’s advanced analytics and personalized strategies, clients can confidently participate in both established and emerging markets. About Virturo Virturo is a next-generation, award-winning multi-asset broker offering CFDs on Equities, Forex, Indices, Commodities, and Cryptocurrencies. Owned by Finastra LTD and operating under stringent GDPR and international financial regulations, Virturo empowers high-net-worth and institutional investors with cutting-edge technology, top-tier security, and a client-centric approach. For more information or to read the latest Virturo review, visit www.virturo.com or contact media@virturo.com. Social Links LinkedIn: https://www.linkedin.com/company/virturo-uk/ YouTube channel: https://www.youtube.com/@Virturo_Official Facebook: https://www.facebook.com/people/Virturo/61570821814759/ Media contact Brand: Virturo Contact: Media team Email: media@virturo.com Website: https://virturo.com

SHENZHEN, CHINA, July 16, 2025 – (ACN Newswire) – On the morning of 15 July 2025, China Medical System Holdings Limited (“CMS” or the “Group”) rang the ceremonial bell to mark its official listing on the Singapore Exchange Main Board (Stock Abbreviation: CMS, Stock Code: 8A8). Nearly one hundred representatives from global professional institutions, shareholders, business partners and employees gathered to witness this strategic moment. Following its successful IPO on the Hong Kong Stock Exchange Main Board in September 2010 , CMS advances with formidable momentum onto the international capital platform, which will attract funds focusing on Asia-Pacific investments and local capital in Southeast Asia to optimize the shareholder structure. This listing also marks a significant milestone for the Group to deepen roots in emerging markets and advance industrial internationalization strategy. At the listing ceremony, Chairman, Chief Executive Officer and President of CMS, Mr. Lam Kong stated: “The secondary listing in Singapore represents a crucial step in implementing CMS’s Asia-Pacific strategy, demonstrating our commitment to extending China’s market advantages across the entire APAC region while strengthening our presence in Southeast Asia and the Middle East. This move not only facilitates CMS’s comprehensive and sustainable development in Asia-Pacific markets, but also enhances our international influence and competitiveness, enabling us to serve broader patient populations with high-quality and affordable medication options.” New CMS New Ascent Over the 33-year journey, CMS has continuously challenged and surpassed itself through three strategic transformations to adapt to the external ecosystem: evolving from “China’s largest CSO” (1992-2010), to “transition from CSO to Pharma” (2010-2018), and since 2018, gradually establishing three core strategies of “Innovation-driven, Specialty Breakthroughs and Industrial Internationalization” to promote the upgrading and iteration of “New CMS”, accumulating momentum for takeoff. CMS has established a comprehensive pharmaceutical product lifecycle management system, covering every stage from target identification to clinical development, product registration and commercialization. The Group focuses on FIC (First-in-Class) and BIC (Best-in-Class) innovative products, and has meticulously built a pipeline of approximately 40 innovative products with differentiated advantages, among which 5 innovative drugs have been approved and successfully commercialized in China. With the impact of VBP (Volume-Based Procurement) mostly cleared, CMS has entered a new cycle of high-quality and sustainable development driven by exclusive and innovative drugs. In specialty fields, the Group focuses on cardio-cerebrovascular, gastroenterology, ophthalmology and skin health, continuously deepening product portfolios and expert networks. Notably, the Group’s skin health business “DERMAVON” has emerged as a leader in its sector and is proposed for an independent listing on the Main Board of the Hong Kong Stock Exchange. A Pioneer in Industrial Internationalization Synergized Development Across the Entire “R&D, Manufacturing and Commercialization” Value Chain Since 2022, CMS has initiated its “Industrial Internationalization” strategy by extending the Group’s advantages and resources from the Chinese market to emerging markets. Utilizing Singapore as the strategic pivot, the Group has established a localized cluster comprising CMS R&D, PharmaGend, and Rxilient, achieving synergized development across the entire pharmaceutical value chain from R&D to production and commercialization, driving deeper and broader market expansion across the Asia-Pacific region. Internationalization of the Commercialization System: Rxilient serves as a platform for drug introduction, R&D and commercialization, operated by a professional and experienced localized team. Headquartered in Singapore, its business has expanded to 14 countries and regions including Malaysia, Thailand, Vietnam, the Philippines, Indonesia, and the Middle East, helping partners from China, the US, and Europe bring innovative drugs to emerging markets while introducing more high-quality and affordable treatment options to local markets. As of now, Rxilient has cumulatively submitted marketing applications for nearly 20 drugs and medical devices across Southeast Asia, the Middle East, Hong Kong, Macao and Taiwan, covering therapeutic areas such as dermatology, ophthalmology, oncology, autoimmune, and central nervous system. Internationalization of the Production System: PharmaGend, as an international CDMO platform based in Singapore, has a site spanning 30,000 square meters and is capable of manufacturing dosage forms such as tablets and capsules, with plans to expand production lines for injections, ointments, and nasal sprays. The factory has been certified by international authorities such as the FDA and the HSA, demonstrating its high-standard pharmaceutical manufacturing capabilities for global export . Structural factors including large population bases, healthcare insurance expansion and rising chronic disease burdens are transforming Southeast Asia, the Middle East and other emerging markets into new growth engines for the global pharmaceutical industry. Leveraging its integrated ecosystem, CMS is forming a novel model for Chinese pharmaceutical globalization – not only enabling incremental market conversion for its own products in emerging markets, but also providing global partners with a reliable one-stop solution, thereby generating additional growth momentum for the Group. Looking ahead, CMS will continue advancing its three core strategies to build the long-term value system of “New CMS”. By persistently enhancing accessibility to pharmaceutical innovation, CMS aims to benefit more patients, achieve sustainable healthy development, and deliver substantial value returns to investors. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd.

Kuala Lumpur, Malaysia – July 16, 2025 – (SeaPRwire) – maxWin Sports (https://maxwinofficial.com) today joins EBM-GIGA Racing Team as a Brand Partner and will be making the company’s motorsports debut in the Malaysian round of the AUTOBACS SUPER GT series held at the Petronas Sepang International Circuit. The sponsorship will also include selected rounds in the GT World Challenge Asia series. EBM-GIGA Racing Team will be spearheaded by Malaysian veteran racer Adrian D’Silva who will team up alongside Frenchman Dorian Boccolacci driving a Porsche 911 GT3R (992) in the GT300 Class this weekend. “Our Brand Partnership underlines maxWin Sports’ “Beyond Limits” which is an initiative to champion local Malaysian athletes,” said maxWin Sports’ Chief Executive Officer James Stapleton. “The goal is to empower Malaysian sports, to support Malaysia’s growing sports ecosystem and to make an impact in the local sports industry. We are aiming at inspiring the next generation of athletes in Malaysia. This aligns with maxWin’s broader mission of giving back to the community and fostering excellence beyond the digital space.” The 59-year-old D’Silva has 146 race starts to his credit and will be making his first appearance in SUPER GT. D’Silva’s career highlights include multiple appearances in the Asian Le Mans series and GT World Challenge Asia since 2010, and the Porsche Carrera Cup Asia, where he currently competes driving for Earl Bamber Motorsport. In 2021, he participated in the Spa-Francorchamps 24-Hour race with EBM Giga Racing, a 100 percent Malaysian-owned team. His achievements include a 3rd place finish at the Sepang 12 Hours in 2023, 4th in LMP3 at Asian Le Mans 2016, 4th in 2013 and 5th in 2014 at the Merdeka Endurance Race, and 3rd in the Asian Touring Car Series in 2009. Boccolacci meanwhile, joins the team with 239 race starts. Having successfully competed in a number of single-seater categories, winning races in GP3 and competing in FIA Formula 2 among other things, Boccolacci garnered success in GT cars, winning the V6 class at the 2020 24 Hours of Nurburgring and becoming the 2023 champion of the Porsche Carrera Cup France. The Autobacs SUPER GT returns to Malaysia after an absence of 12 years and will be staged for three years following the signing of an agreement between HARO Sports & Entertainment as the rights holder and promoter for the Malaysian round of the SUPER GT and the GT Association (GTA) as the rights holders for SUPER GT. The Malaysian round of the 2025 Autobacs SUPER GT race will be run over a distance of 300km and will be the third round of the 2025 race calendar which features a total of eight rounds – seven of which will take place in various circuits within Japan. Malaysia will remain as the ONLY overseas race for Super GT. The weekend concluded on a high note, with the EBM-GIGA Racing Team receiving the Best Team Performance Award, a recognition of their outstanding teamwork and competitive spirit throughout the event. About maxWin maxWin is one of the most trusted online casinos in Malaysia, holding authorization and licenses to operate in various countries such as Malaysia, Vietnam, Indonesia, Thailand, Cambodia, the Philippines, India, and Korea. As a Malaysia online casino featured among the best online casinos in Asia for 2024, we are recognized as one of the premier online casinos. About SUPER GT SUPER GT features the top manufacturers and drivers from Japan competing in the GT500 and GT300 Classes, attracting the best of Japanese manufacturers the likes of Nissan, Lexus, Toyota, Honda and Subaru, as well as continental marques that include Aston Martin, Lamborghini, Mercedes-Benz, Ferrari and BMW. Social Links Facebook: https://www.facebook.com/maXwin.Official88/ Instagram: https://www.instagram.com/maxwin.my/ YouTube: https://www.youtube.com/@maXwinofficial-88 Website: https://maxwinofficial.com

Dubai, UAE – July 14, 2025 – (SeaPRwire) – BlockBits, crypto futures trading platform, launch a new tool for advanced futures trading for higher potential returns with up to 200x leverage. As cryptocurrency markets mature and price swings become more extreme, active traders are increasingly turning to risk management strategies once reserved for traditional finance. One strategy gaining notable traction is hedging – protecting open positions by opening an opposing trade to balance potential losses. Unlike in stocks or commodities, hedging in crypto has only recently become practical for a wider range of traders. With the expansion of futures and perpetual contracts, traders can now offset price movements without selling or transferring their core holdings – a key advantage for long-term investors facing short-term market uncertainty. “For example, a trader holding a major crypto asset can hedge against sudden volatility by opening a short futures position. If the asset’s price drops, gains from the short can help offset losses on the original holding – providing greater peace of mind in unpredictable conditions”, – said in company. Recognizing this growing need, several crypto exchanges are now integrating built-in hedging tools. Features such as the ability to hold both long and short positions on the same pair within a single account are making once-complex strategies more accessible. This is especially important for traders using high leverage or delta-neutral approaches, where profits and losses on opposite positions can balance each other out. Such tools also reduce trading costs by avoiding the need to close and reopen positions repeatedly – a process that can rack up fees and slippage in fast-moving markets. A smoother, single-interface experience means traders can react faster to market shifts without interrupting their broader investment plans. One platform at the forefront of this trend is BlockBits, which has designed its trading environment specifically with hedging in mind. Users can open long and short positions simultaneously on the same pair, track risk and margin separately, and monitor real-time profit/loss and liquidation levels across both sides. In a recent example with the ETH/USDT pair, BlockBits traders were able to hold dual up to 200× leverage positions – a feature not always offered by other exchanges. By integrating hedging into the core trading interface, platforms like BlockBits are helping crypto derivatives mature – providing tools that cater to both aggressive trading and robust risk management. As more traders seek to balance exposure without sacrificing opportunity, such innovations are set to become a standard part of the crypto futures landscape. Contact information Brand: BlockBits Contact: Media team E-mail: info@blockbitstech.com Website: https://blockbitstech.com/en

[caption id="attachment_4638" align="aligncenter" width="1024"] Andy Lin, President of WTCC JC. (Photography: Hua Yeh)[/caption] July 27, 2025 - (SeaPRwire) - According to a report published by "The Icons", Andy Lin, President of the World Taiwanese Chambers of Commerce Junior Chapter (WTCC JC), is redefining youth leadership for the global Chinese community. Through music, education, diplomacy, and social action, Lin exemplifies a new generation of cross-disciplinary cultural leaders, using his talents and compassion to build meaningful bridges between cultures and communities. A classically trained musician who moved to the U.S. at the age of 12, Lin earned a full scholarship to The Juilliard School and later obtained his Doctor of Musical Arts degree from Stony Brook University. As the first and only musician in Juilliard's history to perform concertos on both viola and erhu, his performances have graced the stages of Carnegie Hall and Lincoln Center, earning acclaim for fusing Eastern and Western musical traditions. But Lin's work transcends the concert stage. During the COVID-19 pandemic, he founded Farm2Manhattan, a platform connecting struggling farmers with city-based restaurants to address food distribution challenges. He also joined Concerts in Motion, performing for isolated elderly individuals and bringing music into the lives of those in need. His housing assistance platform, "NYC Housing Multiple-Choice Test," has supported over 16,000 international students in New York, helping them find safe and fair accommodation. In the field of education, Lin launched a music education center in Vietnam in 2025, combining local cultural roots with a global outlook. He is committed to nurturing emotional intelligence, empathy, and cultural awareness in children through music. "Music is not just about teaching skills," Lin affirms, "It's about awakening the soul and building the foundation for responsible global citizenship." His educational initiatives align closely with the United Nations Sustainable Development Goals (SDGs), earning him the U.S. Presidential Volunteer Service Gold Award in 2023. "Leadership is not about displaying power," Lin states. "It's about carrying responsibility. Real change doesn't require a perfect starting point - it begins the moment you choose to believe." From community development to international cultural diplomacy, Lin's work demonstrates that culture is not confined to ivory towers - it is a gentle but powerful force that engages directly with the world. His journey has become a new roadmap for young global Chinese leaders seeking to blend heritage with impact.

[caption id="attachment_4638" align="aligncenter" width="1024"] Andy Lin, President of WTCC JC. (Photography: Hua Yeh)[/caption] July 27, 2025 - (SeaPRwire) - According to a report published by "The Icons", Andy Lin, President of the World Taiwanese Chambers of Commerce Junior Chapter (WTCC JC), is redefining youth leadership for the global Chinese community. Through music, education, diplomacy, and social action, Lin exemplifies a new generation of cross-disciplinary cultural leaders, using his talents and compassion to build meaningful bridges between cultures and communities. A classically trained musician who moved to the U.S. at the age of 12, Lin earned a full scholarship to The Juilliard School and later obtained his Doctor of Musical Arts degree from Stony Brook University. As the first and only musician in Juilliard's history to perform concertos on both viola and erhu, his performances have graced the stages of Carnegie Hall and Lincoln Center, earning acclaim for fusing Eastern and Western musical traditions. But Lin's work transcends the concert stage. During the COVID-19 pandemic, he founded Farm2Manhattan, a platform connecting struggling farmers with city-based restaurants to address food distribution challenges. He also joined Concerts in Motion, performing for isolated elderly individuals and bringing music into the lives of those in need. His housing assistance platform, "NYC Housing Multiple-Choice Test," has supported over 16,000 international students in New York, helping them find safe and fair accommodation. In the field of education, Lin launched a music education center in Vietnam in 2025, combining local cultural roots with a global outlook. He is committed to nurturing emotional intelligence, empathy, and cultural awareness in children through music. "Music is not just about teaching skills," Lin affirms, "It's about awakening the soul and building the foundation for responsible global citizenship." His educational initiatives align closely with the United Nations Sustainable Development Goals (SDGs), earning him the U.S. Presidential Volunteer Service Gold Award in 2023. "Leadership is not about displaying power," Lin states. "It's about carrying responsibility. Real change doesn't require a perfect starting point - it begins the moment you choose to believe." From community development to international cultural diplomacy, Lin's work demonstrates that culture is not confined to ivory towers - it is a gentle but powerful force that engages directly with the world. His journey has become a new roadmap for young global Chinese leaders seeking to blend heritage with impact.